Published in Stroke on September 18, 2012
Basilar Artery International Cooperation Study (BASICS) | NCT01717755
The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial. Trials (2013) 1.06
Predictors of a Good Outcome after Endovascular Stroke Treatment with Stent Retrievers. ScientificWorldJournal (2015) 0.82
Mechanical thrombectomy in patients with acute vertebrobasilar occlusion using the Trevo device: a single-centre experience. Neuroradiology (2014) 0.82
Different Imaging Strategies in Patients With Possible Basilar Artery Occlusion: Cost-Effectiveness Analysis. Stroke (2015) 0.78
Childhood basilar artery occlusion: a report of 5 cases and review of the literature. J Child Neurol (2013) 0.77
Intravenous Versus Intra-arterial Thrombolysis for Acute Ischemic Stroke Secondary to Basilar Artery Occlusion. J Cerebrovasc Endovasc Neurosurg (2014) 0.77
Endovascular revascularization for basilar artery occlusion. Interv Neurol (2015) 0.75
Ultrasound guided V3 segment vertebral artery direct percutaneous puncture for basilar artery mechanical thrombectomy in acute stroke: a technical report. BMJ Case Rep (2013) 0.75
Sensitivity of Hyperdense Basilar Artery Sign on Non-Enhanced Computed Tomography. PLoS One (2015) 0.75
The catastrophic basilar artery occlusion. BMJ Case Rep (2013) 0.75
Endovascular stroke treatment in a small-volume stroke center. Brain Behav (2017) 0.75
Outcomes of endovascular mechanical thrombectomy and intravenous tissue plasminogen activator for the treatment of vertebrobasilar stroke. J Clin Neurol (2014) 0.75
Coma of unknown origin in the emergency department: implementation of an in-house management routine. Scand J Trauma Resusc Emerg Med (2016) 0.75
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med (1991) 5.69
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet (2011) 5.17
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet (2003) 4.19
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol (2009) 3.89
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med (2006) 3.80
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol (2011) 3.73
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol (2009) 3.66
Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke (2007) 3.59
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA (2011) 3.40
The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care (2005) 3.36
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol (2010) 3.35
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet (2012) 3.14
The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J (2005) 3.06
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol (2009) 2.78
Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes (2006) 2.77
Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med (2012) 2.65
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation (2008) 2.42
Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke (2005) 2.41
Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol (2011) 2.38
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol (2009) 2.37
Preoperative diagnosis of carotid artery stenosis: accuracy of noninvasive testing. Stroke (2002) 2.37
Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke (2007) 2.36
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Treatment of space-occupying cerebral infarction. Crit Care Med (2003) 2.14
Air quality, stroke, and coronary events: results of the Heinz Nixdorf Recall Study from the Ruhr Region. Dtsch Arztebl Int (2015) 2.10
Nurses' prediction of volume status after aneurysmal subarachnoid haemorrhage: a prospective cohort study. Crit Care (2008) 2.06
Magnetic resonance imaging for quantitative flow measurement in infants with hydrocephalus: a prospective study. J Neurosurg Pediatr (2008) 2.05
Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke (2006) 1.99
Trigger factors and their attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke (2011) 1.96
Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol (2008) 1.91
Growth rates of intracranial aneurysms: exploring constancy. J Neurosurg (2008) 1.85
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood (2011) 1.78
Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery (2002) 1.76
Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J (2005) 1.75
Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev (2010) 1.74
Basilar artery occlusion. Lancet Neurol (2011) 1.72
Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ (2011) 1.70
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood (2003) 1.70
Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis (2009) 1.69
Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke (2007) 1.65
Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology (2004) 1.64
Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology (2008) 1.64
Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol (2012) 1.63
Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care (2010) 1.61
Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta (2008) 1.60
The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J (2004) 1.59
Trends in worldwide volume and methodological quality of surgical randomized controlled trials. Ann Surg (2013) 1.50
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46
Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev (2015) 1.46
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2013) 1.45
Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes (2006) 1.44
Blood pressure and progression of cerebral atrophy in patients with vascular disease. Am J Hypertens (2009) 1.41
Prevalence of intracranial large artery stenosis and occlusion in patients with acute ischaemic stroke or TIA. Neurol Sci (2014) 1.41
Thrombolysis in stroke despite contraindications or warnings? Stroke (2013) 1.40
Prothrombotic gene variation in patients with large and small vessel disease. Neuroepidemiology (2008) 1.40
Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia (2007) 1.39
[Secondary prevention with clopidogrel after TIA or stroke]. Ned Tijdschr Geneeskd (2013) 1.39
Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties. Neurology (2009) 1.39
Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis (2004) 1.38
Beyond herniation. Clin Neurol Neurosurg (2012) 1.38
Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci (2010) 1.34
Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab (2003) 1.33